Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 187036, 12 pages
http://dx.doi.org/10.1155/2014/187036
Research Article

Alleviative Effects of a Kampo (a Japanese Herbal) Medicine “Maoto (Ma-Huang-Tang)” on the Early Phase of Influenza Virus Infection and Its Possible Mode of Action

1Department of Drug Discovery Sciences, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
2Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
3Oriental Medicine Research Center, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8642, Japan

Received 25 November 2013; Revised 17 January 2014; Accepted 25 January 2014; Published 20 March 2014

Academic Editor: Ken Yasukawa

Copyright © 2014 Takayuki Nagai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. APPENDIX—Composition and Indications of 148 Prescriptions, “Current Kampo medicine 2005,” The Journal of Kampo, Acupuncture and Integrative Medicine, vol. 1, pp. 85–101, 2006. View at Google Scholar
  2. T. Kubo and H. Nishimura, “Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children,” Phytomedicine, vol. 14, no. 2-3, pp. 96–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Toriumi, T. Kamei, K. Murata, I. Takahashi, N. Suzuki, and O. Mazda, “Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed—a clinical, non-randomized study in children,” Forschende Komplementärmedizin, vol. 19, no. 4, pp. 179–186, 2012. View at Google Scholar
  4. S. Nabeshima, K. Kashiwagi, K. Ajisaka et al., “A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza,” Journal of Infection and Chemotherapy, vol. 18, no. 4, pp. 534–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Mantani, T. Andoh, H. Kawamata, K. Terasawa, and H. Ochiai, “Inhibitory effect of Ephedrae herba, an oriental traditional medicine, on the growth of influenza A/PR/8 virus in MDCK cells,” Antiviral Research, vol. 44, no. 3, pp. 193–200, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Hayashi, N. Imanishi, Y. Kashiwayama et al., “Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo,” Antiviral Research, vol. 74, no. 1, pp. 1–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Utsunomiya, M. Kobayashi, R. B. Pollard, and F. Suzuki, “Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 3, pp. 551–556, 1997. View at Google Scholar · View at Scopus
  8. R. Pompei, L. Paghi, A. Ingianni, and P. Uccheddu, “Glycyrrhizic acid inhibits influenza virus growth in embryonated eggs,” Microbiologica, vol. 6, no. 3, pp. 247–250, 1983. View at Google Scholar · View at Scopus
  9. R. Pompei, O. Flore, and M. A. Marccialis, “Glycyrrhizic acid inhibits virus growth and inactivates virus particles,” Nature, vol. 281, no. 5733, pp. 689–690, 1979. View at Google Scholar · View at Scopus
  10. T. Nagai and H. Yamada, “In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine “Sho-seiryu-to” and its mode of action,” International Journal of Immunopharmacology, vol. 16, no. 8, pp. 605–613, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. S.-I. Tamura, H. Asanuma, Y. Ito et al., “Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine,” European Journal of Immunology, vol. 22, no. 2, pp. 477–481, 1992. View at Google Scholar · View at Scopus
  12. T. Nagai, Y. Arai, M. Emori et al., “Anti-allergic activity of a Kampo (Japanese herbal) medicine “Sho-seiryu-to (Xiao-Qing-Long-Tang)” on airway inflammation in a mouse model,” International Immunopharmacology, vol. 4, no. 10-11, pp. 1353–1365, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Nagai, M. Nakao, Y. Shimizu et al., “Proteomic analysis of anti-inflammatory effects of a Kampo (Japanese Herbal) medicine “shoseiryuto (Xiao-Qing-Long-Tang)” on airway inflammation in a mouse model,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 604196, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Hokari, T. Nagai, and H. Yamada, “In vivo anti-influenza virus activity of Japanese herbal (Kampo) medicine, “Shahakusan,” and its possible mode of action,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 794970, 13 pages, 2012. View at Publisher · View at Google Scholar
  15. F. M. Davenport, A. V. Hennessy, F. M. Brandon, R. G. Webster, C. D. Barrett Jr., and G. O. Lease, “Comparisons of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinins,” The Journal of Laboratory and Clinical Medicine, vol. 63, no. 1, pp. 5–13, 1964. View at Google Scholar · View at Scopus
  16. T. Nagai, Y. Suzuki, T. Tomimori, and H. Yamada, “Antiviral activity of plant flavonoid 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B virus,” Biological & Pharmaceutical Bulletin, vol. 18, no. 2, pp. 295–299, 1995. View at Google Scholar · View at Scopus
  17. T. Nagai, S. Makino, S. Ikegami, H. Itoh, and H. Yamada, “Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 and its exopolysaccharides against influenza virus infection in mice,” International Immunopharmacology, vol. 11, no. 12, pp. 2246–2250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Sawamura, T. Shimizu, Y. Sun et al., “In vitro and in vivo anti-influenza virus activity of diarylheptanoids isolated from Alpinia officinarum,” Antiviral Chemistry and Chemotherapy, vol. 21, no. 1, pp. 33–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kiyohara, C. Ichino, Y. Kawamura, T. Nagai, N. Sato, and H. Yamada, “Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth,” Journal of Natural Medicines, vol. 66, no. 1, pp. 55–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sakaguchi, S. Inouye, H. Miyazawa, and S. Tamura, “Measurement of antigen-specific mouse IgE by a fluorometric reverse (IgE-capture) ELISA,” Journal of Immunological Methods, vol. 116, no. 2, pp. 181–187, 1989. View at Publisher · View at Google Scholar · View at Scopus
  21. J. R. Whittle, R. Zhang, S. Khurana et al., “Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 34, pp. 14216–14221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Johann, G. Blümel, M. Lipp, and R. Förster, “A versatile flow cytometry-based assay for the determination of short- and long-term natural killer cell activity,” Journal of Immunological Methods, vol. 185, no. 2, pp. 209–216, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Makino, S. Ikegami, H. Kano et al., “Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1,” Journal of Dairy Science, vol. 89, no. 8, pp. 2873–2881, 2006. View at Google Scholar · View at Scopus
  24. C. A. Dinarello, J. G. Cannon, and S. M. Wolff, “New concepts on the pathogenesis of fever,” Reviews of Infectious Diseases, vol. 10, no. 1, pp. 168–189, 1988. View at Google Scholar · View at Scopus
  25. M. Kurokawa, M. Imakita, C. A. Kumeda, and K. Shiraki, “Cascade of fever production in mice infected with influenza virus,” Journal of Medical Virology, vol. 50, no. 2, pp. 152–158, 1996. View at Google Scholar
  26. M. Kurokawa, M. Imakita, C. A. Kumeda, T. A. Yukawa, and K. Shiraki, “Kakkon-to suppressed interleukin-1α production responsive to interferon and alleviated influenza infection in mice,” Journal of Traditional Medicines, vol. 13, no. 3, pp. 201–209, 1996. View at Google Scholar
  27. M. Kurokawa, C. A. Kumeda, J.-I. Yamamura, T. Kamiyama, and K. Shiraki, “Antipyretic activity of cinnamyl derivatives and related compounds in influenza virus-infected mice,” European Journal of Pharmacology, vol. 348, no. 1, pp. 45–51, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Nagai, M. Urata, and H. Yamada, “In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine “Sho-seiryu-to”—effects on aged mice, against subtypes of A viruses and B virus, and therapeutic effect,” Immunopharmacology and Immunotoxicology, vol. 18, no. 2, pp. 193–208, 1996. View at Google Scholar · View at Scopus
  29. T. Nagai and H. Yamada, “In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine “Sho-seiryu-to”—stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice,” Immunopharmacology and Immunotoxicology, vol. 20, no. 2, pp. 267–281, 1998. View at Google Scholar · View at Scopus
  30. H. Yamada and T. Nagai, “In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 20, no. 3, pp. 185–192, 1998. View at Google Scholar · View at Scopus
  31. N. Baumgarth, O. C. Herman, G. C. Jager, L. Brown, L. A. Herzenberg, and L. A. Herzenberg, “Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2250–2255, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Baumgarth, O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen, “B-1 and b-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection,” The Journal of Experimental Medicine, vol. 192, no. 2, pp. 271–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Savitsky and K. Calame, “B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion,” The Journal of Experimental Medicine, vol. 203, no. 10, pp. 2305–2314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. S. Choi and N. Baumgarth, “Dual role for B-1a cells in immunity to influenza virus infection,” The Journal of Experimental Medicine, vol. 205, no. 13, pp. 3053–3064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Baumgarth, “The double life of a B-1 cell: self-reactivity selects for protective effector functions,” Nature Reviews Immunology, vol. 11, no. 1, pp. 34–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. J. Macpherson, “IgA adaptation to the presence of commensal bacteria in the intestine,” Current Topics in Microbiology and Immunology, vol. 308, pp. 117–136, 2006. View at Google Scholar · View at Scopus
  37. S. Fagarasan and T. Honjo, “T-independent immune response: new aspects of B cell biology,” Science, vol. 290, no. 5489, pp. 89–92, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. R. Marcos, F. Huetz, P. Pereira, J.-L. Andreu, C. Martinez, and A. Coutinho, “Further evidence for coelomic-associated B lymphocytes,” European Journal of Immunology, vol. 19, no. 11, pp. 2031–2035, 1989. View at Publisher · View at Google Scholar · View at Scopus
  39. F. G. M. Kroese, W. A. M. Ammerlaan, and G. J. Deenen, “Location and function of B-cell lineages,” Annals of the New York Academy of Sciences, vol. 651, pp. 44–58, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Berland and H. H. Wortis, “Origins and functions of B-1 cells with notes on the role of CD5,” Annual Review of Immunology, vol. 20, pp. 253–300, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Murakami and T. Honjo, “B-1 cells and autoimmunity,” Annals of the New York Academy of Sciences, vol. 764, pp. 402–409, 1995. View at Google Scholar · View at Scopus
  42. M. Murakami and T. Honjo, “Involvement of B-1 cells in mucosal immunity and autoimmunity,” Immunology Today, vol. 16, no. 11, pp. 534–539, 1995. View at Publisher · View at Google Scholar · View at Scopus